Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the … C Théry, KW Witwer, E Aikawa, MJ Alcaraz, JD Anderson, ... Journal of extracellular vesicles 7 (1), 1535750, 2018 | 8883 | 2018 |
Safety of nanoparticles in medicine J Wolfram, M Zhu, Y Yang, J Shen, E Gentile, D Paolino, M Fresta, G Nie, ... Current drug targets 16 (14), 1671-1681, 2015 | 548 | 2015 |
Clinical cancer nanomedicine J Wolfram, M Ferrari Nano today 25, 85-98, 2019 | 408 | 2019 |
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches JA Welsh, DCI Goberdhan, L O'Driscoll, EI Buzas, C Blenkiron, ... Journal of extracellular vesicles 13 (2), e12404, 2024 | 385 | 2024 |
Tangential flow filtration for highly efficient concentration of extracellular vesicles from large volumes of fluid S Busatto, G Vilanilam, T Ticer, WL Lin, DW Dickson, S Shapiro, ... Cells 7 (12), 273, 2018 | 345 | 2018 |
Insights from nanomedicine into chloroquine efficacy against COVID-19 TY Hu, M Frieman, J Wolfram Nature nanotechnology 15 (4), 247-249, 2020 | 344 | 2020 |
Extracellular vesicle-based drug delivery systems for cancer treatment S Walker, S Busatto, A Pham, M Tian, A Suh, K Carson, A Quintero, ... Theranostics 9 (26), 8001, 2019 | 325 | 2019 |
Extracellular vesicles versus synthetic nanoparticles for drug delivery KW Witwer, J Wolfram Nature Reviews Materials 6 (2), 103-106, 2021 | 242 | 2021 |
The nano-plasma interface: Implications of the protein corona J Wolfram, Y Yang, J Shen, A Moten, C Chen, H Shen, M Ferrari, Y Zhao Colloids and Surfaces B: Biointerfaces 124, 17-24, 2014 | 225 | 2014 |
Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics J Shen, HC Kim, H Su, F Wang, J Wolfram, D Kirui, J Mai, C Mu, LN Ji, ... Theranostics 4 (5), 487, 2014 | 191 | 2014 |
Anticancer activity of liposomal bergamot essential oil (BEO) on human neuroblastoma cells C Celia, E Trapasso, M Locatelli, M Navarra, CA Ventura, J Wolfram, ... Colloids and Surfaces B: Biointerfaces 112, 548-553, 2013 | 183 | 2013 |
On the issue of transparency and reproducibility in nanomedicine HS Leong, KS Butler, CJ Brinker, M Azzawi, S Conlan, C Dufès, A Owen, ... Nature nanotechnology 14 (7), 629-635, 2019 | 175 | 2019 |
Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy G Pasut, D Paolino, C Celia, A Mero, AS Joseph, J Wolfram, D Cosco, ... Journal of controlled release 199, 106-113, 2015 | 166 | 2015 |
A chloroquine-induced macrophage-preconditioning strategy for improved nanodelivery J Wolfram, S Nizzero, H Liu, F Li, G Zhang, Z Li, H Shen, E Blanco, ... Scientific reports 7 (1), 13738, 2017 | 136 | 2017 |
The solid progress of nanomedicine JP Martins, J Das Neves, M de la Fuente, C Celia, H Florindo, ... Drug delivery and translational research 10, 726-729, 2020 | 131 | 2020 |
Shrinkage of pegylated and non-pegylated liposomes in serum J Wolfram, K Suri, Y Yang, J Shen, C Celia, M Fresta, Y Zhao, H Shen, ... Colloids and surfaces B: biointerfaces 114, 294-300, 2014 | 124 | 2014 |
A liposome encapsulated ruthenium polypyridine complex as a theranostic platform for triple-negative breast cancer J Shen, HC Kim, J Wolfram, C Mu, W Zhang, H Liu, Y Xie, J Mai, H Zhang, ... Nano letters 17 (5), 2913-2920, 2017 | 121 | 2017 |
Extracellular vesicle therapeutics for liver disease DA Borrelli, K Yankson, N Shukla, G Vilanilam, T Ticer, J Wolfram Journal of Controlled Release 273, 86-98, 2018 | 117 | 2018 |
High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics J Shen, R Xu, J Mai, HC Kim, X Guo, G Qin, Y Yang, J Wolfram, C Mu, ... ACS nano 7 (11), 9867-9880, 2013 | 117 | 2013 |
Hesperetin impairs glucose uptake and inhibits proliferation of breast cancer cells Y Yang, J Wolfram, K Boom, X Fang, H Shen, M Ferrari Cell biochemistry and function 31 (5), 374-379, 2013 | 114 | 2013 |